GlassScriptPhysician profile
Jamie Kwak
NPI 1093306045
$1,319.41
in general payments reported to CMS, 2019-2025
17 companies · $37.21 in 2025
The $37.21 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.89 · 2022: $284 · 2023: $496 · 2024: $472 · 2025: $37.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948 · Education: $57.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.55 |
| Education | $57.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $306.20 | 2022-2025 | Tezspire, Breztri, Fasenra |
| Regeneron Healthcare Solutions, INC. | $222.11 | 2022-2024 | Dupixent |
| Genzyme Corporation | $215.72 | 2022-2024 | |
| Glaxosmithkline, LLC. | $95.24 | 2022-2024 | Trelegy Ellipta, Nucala |
| Amgen INC. | $86.73 | 2022-2024 | Tezspire |
| Optinose US, INC. | $66.90 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.39 | 2023-2025 | Cuvitru, Takhzyro |
| Sanofi-Aventis U.S. LLC | $57.48 | 2023 | |
| Blueprint Medicines Corporation | $47.02 | 2024 | Ayvakit |
| Janssen Pharmaceuticals, INC | $29.89 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $22.33 | 2022 | |
| Incyte Corporation | $21.61 | 2024 | Opzelura |
| Leo Pharma INC. | $21.40 | 2022 | |
| Lilly USA, LLC | $21.10 | 2024 | Zepbound |
| Currax Pharmaceuticals LLC | $17.32 | 2023 | Contrave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.46 | 2022 | |
| Pfizer INC. | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Kwak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.